Opportunity
Simpler Grants.gov #PAR-25-369
NIH ELSI Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
Buyer
National Institutes of Health
Posted
January 13, 2025
Respond By
November 18, 2026
Identifier
PAR-25-369
NAICS
541720, 541715, 541714
The National Institutes of Health (NIH) is seeking research services through the ELSI Exploratory/Developmental Research Grant (R21 Clinical Trial Optional): - Government Buyer: - National Institutes of Health (NIH) - Products/Services Requested: - Research services focused on the ethical, legal, and social implications (ELSI) of human genetics and genomics - Studies may use qualitative, quantitative, conceptual, legal, or normative methods - Emphasis on new or emerging genomic technologies and novel uses of genomic information - OEMs and Vendors: - No specific OEMs or vendors are referenced; this is a grant for research services only - Unique or Notable Requirements: - Open to a wide range of applicants, including government, business, nonprofit, educational, tribal, and international organizations - No cost sharing or matching required - Funding instrument is a grant, not a contract - Clinical trials are optional under this opportunity
Description
This funding opportunity invites Exploratory/Developmental Research Grant (R21) applications to study the ethical, legal, and social implications of human genetics and genomics. Proposed studies may use single or mixed methods including empirical qualitative and quantitative methods, as well as conceptual, legal, and normative analyses. The research should involve key stakeholders where appropriate and focus on implications of new or emerging genomic technologies or novel uses of genomic information. The grant is provided by the National Institutes of Health and supports research in various health and social science areas.